Oruka Therapeutics, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
ORKA on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
855 Oak Grove Ave., Suite 100, Menlo Park, CA

Insiders trading volume in the past year

Oruka Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fairmount Funds Management LLC Director, 10%+ Owner $77.6M Nov 19, 2024
Funicular Funds, LP Other*, 10%+ Owner $22.9M Dec 15, 2022
Funicular Fund, LP Other* $6.45M May 23, 2022
Janus Henderson Group Plc 10%+ Owner $6.3M +$2.14M +51.5% Aug 16, 2024
Lawrence Klein President and CEO, Director $2.54M Aug 29, 2024
Cameron Turtle Director $254K Aug 29, 2024
Christopher David Ozeroff S.V.P., General Counsel $127K Dec 14, 2021
Robert E. Conway Director, Chairman of the Board $125K Jan 30, 2024
Thomas A. Keuer Chief Operating Officer $102K Dec 8, 2022
C. Jeffrey Dekker Chief Financial Officer $100K Dec 8, 2022
Michael R. Bristow Pres. & Chief Executive Offic, Director $12K Dec 14, 2021
Daniel J. Mitchell Director $1.53K Jan 30, 2024
James P. Flynn Director Jan 30, 2024
Linda Grais Director Jan 30, 2024
Raymond L. Woosley Director Jan 30, 2024
Jacob Ma-Weaver Other* Aug 29, 2024
Anders D. Hove Director Jan 30, 2024
Samarth Kulkarni Director Aug 29, 2024
Carl Dambkowski Director Aug 29, 2024
Kristine Ball Director Aug 29, 2024
Arjun Agarwal SVP, Finance and Treasurer Aug 29, 2024
Joana Goncalves Chief Medical Officer Aug 29, 2024
Paul Quinlan General Counsel and Secretary Aug 29, 2024

Recent Insider Transactions by Companies or Individuals for Oruka Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.